The Efficacy and Safety of The Fuzuloparib Combination With Bevacizumab

NCT05819060 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Ovarian Cancer

Interventions

DRUG: Fuzuloparib Combination with Bevacizumab

Sponsor

Fudan University